APPLICATION
ANDA090130
TYPE
ANDA
ORIGINAL APPROVAL
2009-12-09
LATEST ACTION
2024-01-27
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
PACLITAXELPrescription
PACLITAXEL 6MG/ML · INJECTABLE · INJECTION
Approval history
2024-01-27Labeling · Supplement 4 · standardAP
2011-11-18Labeling · Supplement 3AP
2011-07-14Labeling · Supplement 2AP
2009-12-09OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.